189 related articles for article (PubMed ID: 23698301)
1. Epstein-Barr virus latent membrane protein 2A contributes to anoikis resistance through ERK activation.
Iwakiri D; Minamitani T; Samanta M
J Virol; 2013 Jul; 87(14):8227-34. PubMed ID: 23698301
[TBL] [Abstract][Full Text] [Related]
2. Role of the immunoreceptor tyrosine-based activation motif of latent membrane protein 2A (LMP2A) in Epstein-Barr virus LMP2A-induced cell transformation.
Fukuda M; Kawaguchi Y
J Virol; 2014 May; 88(9):5189-94. PubMed ID: 24554661
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus latent membrane protein 2 effects on epithelial acinus development reveal distinct requirements for the PY and YEEA motifs.
Fotheringham JA; Raab-Traub N
J Virol; 2013 Dec; 87(24):13803-15. PubMed ID: 24109232
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus latent membrane protein-2A induces ITAM/Syk- and Akt-dependent epithelial migration through αv-integrin membrane translocation.
Fotheringham JA; Coalson NE; Raab-Traub N
J Virol; 2012 Oct; 86(19):10308-20. PubMed ID: 22837212
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia suppression of Bim and Bmf blocks anoikis and luminal clearing during mammary morphogenesis.
Whelan KA; Caldwell SA; Shahriari KS; Jackson SR; Franchetti LD; Johannes GJ; Reginato MJ
Mol Biol Cell; 2010 Nov; 21(22):3829-37. PubMed ID: 20861305
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus latent membrane protein 2A regulates c-Jun protein through extracellular signal-regulated kinase.
Chen SY; Lu J; Shih YC; Tsai CH
J Virol; 2002 Sep; 76(18):9556-61. PubMed ID: 12186939
[TBL] [Abstract][Full Text] [Related]
7. Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.
Wasil LR; Wei L; Chang C; Lan L; Shair KH
J Virol; 2015 Aug; 89(15):7612-24. PubMed ID: 25972552
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus LMP2A suppresses MHC class II expression by regulating the B-cell transcription factors E47 and PU.1.
Lin JH; Lin JY; Chou YC; Chen MR; Yeh TH; Lin CW; Lin SJ; Tsai CH
Blood; 2015 Apr; 125(14):2228-38. PubMed ID: 25631773
[TBL] [Abstract][Full Text] [Related]
9. G1/S cell cycle arrest provides anoikis resistance through Erk-mediated Bim suppression.
Collins NL; Reginato MJ; Paulus JK; Sgroi DC; Labaer J; Brugge JS
Mol Cell Biol; 2005 Jun; 25(12):5282-91. PubMed ID: 15923641
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency.
Fruehling S; Swart R; Dolwick KM; Kremmer E; Longnecker R
J Virol; 1998 Oct; 72(10):7796-806. PubMed ID: 9733815
[TBL] [Abstract][Full Text] [Related]
11. Roles of the ITAM and PY motifs of Epstein-Barr virus latent membrane protein 2A in the inhibition of epithelial cell differentiation and activation of {beta}-catenin signaling.
Morrison JA; Raab-Traub N
J Virol; 2005 Feb; 79(4):2375-82. PubMed ID: 15681438
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway.
Portis T; Longnecker R
Oncogene; 2004 Nov; 23(53):8619-28. PubMed ID: 15361852
[TBL] [Abstract][Full Text] [Related]
13. The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer.
Pang MF; Lin KW; Peh SC
Cell Mol Biol Lett; 2009; 14(2):222-47. PubMed ID: 19082921
[TBL] [Abstract][Full Text] [Related]
14. K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus.
Steinbrück L; Gustems M; Medele S; Schulz TF; Lutter D; Hammerschmidt W
J Virol; 2015 Jul; 89(14):7248-61. PubMed ID: 25948739
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of host kinase activity altered by the LMP2A signalosome-a therapeutic target for Epstein-Barr virus latency and associated disease.
Cooper L; Longnecker R
Antiviral Res; 2002 Dec; 56(3):219-31. PubMed ID: 12406506
[TBL] [Abstract][Full Text] [Related]
16. Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim.
Paschos K; Smith P; Anderton E; Middeldorp JM; White RE; Allday MJ
PLoS Pathog; 2009 Jun; 5(6):e1000492. PubMed ID: 19557159
[TBL] [Abstract][Full Text] [Related]
17. LMP2A suppresses the role of AHR pathway through ERK signal pathway in EBV-associated gastric cancer.
Jiang Y; Xiao H; Sun L; Zhang Y; Liu S; Luo B
Virus Res; 2021 May; 297():198399. PubMed ID: 33753181
[TBL] [Abstract][Full Text] [Related]
18. The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction.
Fruehling S; Longnecker R
Virology; 1997 Sep; 235(2):241-51. PubMed ID: 9281504
[TBL] [Abstract][Full Text] [Related]
19. Sequence variations of latent membrane protein 2A in Epstein-Barr virus-associated gastric carcinomas from Guangzhou, southern China.
Han J; Chen JN; Zhang ZG; Li HG; Ding YG; Du H; Shao CK
PLoS One; 2012; 7(3):e34276. PubMed ID: 22470549
[TBL] [Abstract][Full Text] [Related]
20. The Epstein-Barr virus encoded latent membrane protein 2A augments signaling from latent membrane protein 1.
Dawson CW; George JH; Blake SM; Longnecker R; Young LS
Virology; 2001 Oct; 289(2):192-207. PubMed ID: 11689042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
